Lyka Labs Ltd

Lyka Labs Limited will hold a board meeting on Friday, October 30, 2026, to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026, along with a limited review report from its statutory auditor, and the results will be available on the company’s website at www.lykalabs.com.

Lyka Labs Limited, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, has received a certificate from MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, for the quarter ended September 30, 2026, confirming the acceptance or rejection of securities received for dematerialisation and their subsequent listing on stock exchanges.

Lyka Labs Limited informed the BSE Limited and National Stock Exchange of India Limited that trading in the company's securities will be closed for "Designated Persons" and their immediate relatives from Thursday, October 1, 2026, until 48 hours after the announcement of the company’s unaudited financial results for the second quarter ending September 30, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Lyka Labs Ltd share price declined by 2% to Rs 67.62 after the company's net profit tumbled by 125.40% to Rs 2.05 crore, while revenue from operations increased sharply by 50.95% to Rs 42.31 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.54 lakh crore, easing 5.14%. It has improved by 0.74% over last one week and rose by 13.39% in last one month while the market capitalization of Lyka Labs Ltd has inched up 6.91% and 10.92% in the same period respectively. Profit before tax (PBT) of Lyka Labs Ltd stood at Rs 1.95 crore in Q2 FY26, expanding by 44.44% year-on-year, and tanking 122.70% quarter-on-quarter. EBITDA came in at Rs 4 crore, jumping 35.41% YoY and plunging by 158.42% sequentially. Total expenses posted a minor rise of 8.87% to Rs 39.77 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 11.2 crore, surging by 50.74% YoY, while employee benefits expense was at Rs 11.49 crore, falling 11% YoY. For the TTM ended FY26, revenue from operations declined slightly by 7.26% to Rs 128.44 crore, while net profit plunged by 231.65% to Rs 10.44 crore, compared to previous TTM. EBITDA soared by 1640% to Rs 7.16 crore, and PBT collapsed by 205.94% to Rs 11.78 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 5.24 crore in FY26, as against Rs 1.9 crore in FY25. Lyka Labs Ltd nosedived by 35.94% in last one year, underperforming the benchmark BSE Sensex which has eased by 2.63% during the same period.

Lyka Labs will hold a meeting of the Board of Directors of the Company on 10 August 2026.

Lyka Labs announced that the 47th Annual General Meeting(AGM) of the company will be held on 10 August 2026.

Net loss of Lyka Labs reported to Rs 7.61 crore in the quarter ended March 2026 as against net profit of Rs 1.77 crore during the previous quarter ended March 2025. Sales declined 16.15% to Rs 28.03 crore in the quarter ended March 2026 as against Rs 33.43 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 10.03 crore in the year ended March 2026 as against net profit of Rs 8.01 crore during the previous year ended March 2025. Sales declined 7.26% to Rs 128.44 crore in the year ended March 2026 as against Rs 138.50 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales28.0333.43 -16 128.44138.50 -7 OPM %-23.0112.20 --2.8512.95 - PBDT-6.544.43 PL -3.3217.89 PL PBT-8.593.02 PL -11.7811.12 PL NP-7.611.77 PL -10.038.01 PL Powered by Capital Market - Live

Lyka Labs will hold a meeting of the Board of Directors of the Company on 25 May 2026.

Lyka Labs will hold a meeting of the Board of Directors of the Company on 31 March 2026.Powered by Capital Market - Live

Lyka Labs reported no net profit/loss in the quarter ended December 2025 as against net profit of Rs 2.70 crore during the previous quarter ended December 2024. Sales declined 9.08% to Rs 30.73 crore in the quarter ended December 2025 as against Rs 33.80 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales30.7333.80 -9 OPM %5.3715.36 - PBDT1.995.41 -63 PBT-0.163.57 PL NP02.70 -100 Powered by Capital Market - Live